Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
87,692,308
-
Total 13F shares
-
53,226,532
-
Share change
-
+3,486,890
-
Total reported value
-
$630,202,113
-
Price per share
-
$11.84
-
Number of holders
-
79
-
Value change
-
+$46,060,367
-
Number of buys
-
53
-
Number of sells
-
29
Institutional Holders of Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN) as of Q1 2023
As of 31 Mar 2023,
Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,226,532 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, Vivo Capital, LLC, VR Adviser, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Fairmount Funds Management LLC, BRAIDWELL LP, and FRANKLIN RESOURCES INC.
This page lists
79
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.